Aflibercept

Category: Vision / Eye Health



Aflibercept Overview

Aflibercept is a biopharmaceutical drug invented by Regeneron Pharmaceuticals, approved in the United States and Europe for the treatment of wet macular degeneration under the trade name Eylea, and for metastatic colorectal cancer as Zaltrap. As the active ingredient of Zaltrap, the substance is called ziv-aflibercept in the US. It is an inhibitor of vascular endothelial growth factor (VEGF).[1][2] Aflibercept is being co-developed for cancer treatment by San...

Read more Aflibercept Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Aflibercept

Recent Aflibercept Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Aflibercept
  • Injection: 40mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Aflibercept or a similar ingredient: (3 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA